About

Company description

FLAMMA is a CDMO with Headquarters near Milan, Italy. As a fully integrated CDMO, we can leverage our 100% self-owned, self-managed facilities, in Italy, China and the USA to deliver a stable, reliable supply chain.

Specializing in the cGMP manufacturing of APIs, NCEs, RSMs & Advanced intermediates (NCEs & generics), we use our expertise in high value chiral materials (specifically amino acid related materials) to provide solutions to customers who not only have need for chiral materials but also clients who have other requirements with a various type of chemistries.
Flamma also manufactures specialty compounds & adv. intermediates for the nutraceutical & cosmetic industries as well as offering a variety of niche generic products.

FLAMMA has four state of the art cGMP manufacturing facilities, each with its own R&D staff and labs.

Italy - Flamma Chignolo has 120 m3 capacity & Flamma Isso has 130 m3 capacity 
China- Flamma Honkai is located outside of Dalian, China with 200 m3 of capacity.  Flamma Honkai provides the security of constant Italian management & oversight. It is like having an Italian facility in China.
USA- Flamma USA is located in Malvern, PA outside of Philadelphia.  Flamma-delpia features a cGMP Pilot Plant, 6 standard cGMP kilo lab suites, 1 cGMP HPAPI kilo lab suite, 22 fume hoods, an analytical development lab as well as a QC lab, and additional space for future expansion for any necessary analytical, chemistry, and/or  warehouse needs.
 
Flamma works on both early stage pre-clinical development of small molecules (multi-kilo) as well as large-scale commercial manufacturing (MT). With over 550 employees and a total capacity of 450 m3 and the flexibility to use three different manufacturing sites and four different R&D labs, see why Flamma is the “go to” contract manufacturer of the pharma industry. Experience the FLAMMA difference today! FLAMMA- The Thinking CDMO™

Quick facts

Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Affiliated categories: API Contract Manufacturing |Biotechnology and related specialities |Custom Manufacturing/Exclusive Synthesis of Fine Chemicals More

Recently at

5 nov 2019

CPhI Worldwide 2019

5-7 November 2019 Frankfurt, Germany We were at stand 41B16 See our Exhibitor Profile   See full Exhibitor List
30 apr 2019

CPhI North America 2019

30 April - 2 May 2019 Chicago, USA We were at stand 921 See our Exhibitor Profile   See full Exhibitor List
9 oct 2018

CPhI Worldwide 2018

9 - 11 October 2018 Madrid, Spain We were at stand 10F43 See our Exhibitor Profile   See full Exhibitor List

News about Flamma S.p.a.

FLAMMA acquires Teva’s Philadelphia cGMP facility marking entry into the US marketplace with labs & pilot plant

5 Aug 2019

FLAMMA acquires Teva’s Philadelphia cGMP facility marking entry into the US marketplace with labs & pilot plant

Flamma SpA (“Flamma”), a preeminent Contract Development and Manufacturing Organization (CDMO) that develops, manufactures, and commercializes small molecule Active Pharmaceutical Ingredients (APIs) for the pharmaceutical industry, is proud to announce that the company has acquired the Teva’s Chemical Synthesis Center in Malvern, PA in the Philadelphia area.

Read more

4 Apr 2019

FLAMMA Opens New cGMP Kilo Lab Suite in Italy and plans construction of new R&D building

Flamma SpA (“Flamma”), a preeminent Contract Development and Manufacturing Organization (CDMO) that develops, manufactures, and commercializes small molecule Active Pharmaceutical Ingredients (APIs) for the pharmaceutical industry, is proud to announce that it has completed the construction of its first cGMP Kilo Lab at its Chignolo D’Isola Headquarters in Italy

Read more

4 Apr 2019

FLAMMA announces the successful CFDA inspection of Flamma Honkai

Flamma SpA (“Flamma”), a preeminent Contract Development and Manufacturing Organization (CDMO) that develops, manufactures, and commercializes small molecule Active Pharmaceutical Ingredients (APIs) for the pharmaceutical industry, is proud to announce that Flamma Honkai has passed its first Chinese FDA (CFDA) inspection.

Read more
Flamma S.p.a.

Contact information

Address

Telephone

Website

View all contact information